Subject:
Re: Bridge Loan
Attachments:
Aqua Sciences Series C Term Sheet Disc.pdf
Eric,
Right now we are working on a bridge "equity' financing. We are currently
in serious discussions with 5 potential investors. This bridge would be
for an amount of up to $3 Million, and would value that round at a 20%
discount to the Barclay's round that we are currently working on.
In addition, we have interest from KKR and other serious financial
investors. I am cautiously optimistic about getting the bridge done at
this point.
I would be happy to discuss with you at your convenience. Best,
Abe
> Abe-
>
> As I mentioned, we might have someone who could help with a bridge loan.
> Do you have some general deal parameters that you are using as you discuss
> this with others? We'd like to have an initial discussion at some point
> with the potential investor but wanted to give him some general parameters
> as to what you were looking for, etc. This may pan out to be nothing,
> but it is someone who has recently done a similar bridge loan deal for one
> of our portfolio companies and he may have an appetite for another. Do
> you have anything you can send me?
>
> Let me know.
>
> Best,
>
> Eric
>
>
>
>
> Eric D. Schwerin
> Rosemont Seneca Partners, LLC
> 1010 Wisconsin Ave., NW
> Suite 705
> Washington, DC 20007
> (202) 333-1880
> eschwerin@rosemontseneca.com
> P Consider the environment before printing this email.
>
>
------------------------------------------------
Abe M. Sher, Chairman & CEO
Aqua Sciences, Inc.
PO Box 403488
Miami Beach, FL 33140
USA
Main: +1-305-655-1460, Ext. 222
Fax: +1-305-655-1464
Email: abe@AquaSciences.com
www.AquaSciences.com
------------------------------------------------
This message may contain confidential, proprietary and/or legally
privileged information and is intended only for the personal and
confidential use of the designated recipient(s) named above. If you are
not the intended recipient of this message you are hereby notified that
any review, dissemination, distribution or copying of this message is
strictly prohibited. If you have received this information in error,
please immediately delete it and copies of it from your system and advise
the sender. You must not, directly or indirectly, use, disclose,
distribute, print or copy any part of this message if you are not the
intended recipient. Thank you.